2,982
Views
0
CrossRef citations to date
0
Altmetric
Review

Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review

, , , , , & show all
Pages 143-154 | Received 19 Jul 2023, Accepted 28 Sep 2023, Published online: 20 Oct 2023

References

  • World Health Organization. Cardiovascular diseases (CVDs) [Internet]. 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
  • Roth Gregory A, Mensah George A, Johnson Catherine O, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019. J Am Coll Cardiol. 2020;76(25):2982–3021. doi: 10.1016/j.jacc.2020.11.010
  • Luengo-Fernandez R, Leal J, Burns R. P4659Economic burden of CVD across the European Union: trends over the last decade. Eur Heart J. 2017;38(suppl_1):ehx504.P4659. doi: 10.1093/eurheartj/ehx504.P4659
  • World Health Organization. Regional Office for Europe. Global atlas on cardiovascular disease prevention and control: published by the World Health Organization in collaboration with the World Heart Federation and the World stroke Organization [Internet]. Copenhagen: World Health Organization. Regional Office for Europe; 2011 [cited 2022 Nov 30]. Available from: https://apps.who.int/iris/handle/10665/329516
  • World Health Organization. Blood pressure/hypertension [Internet]. 2022. Available from: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3155
  • World Health Organization. Raised cholesterol [Internet]. 2022. Available from: https://www.who.int/data/gho/indicator-metadata-registry/imr-details/3236
  • Zodda D, Giammona R, Schifilliti S. Treatment strategy for dyslipidemia in cardiovascular disease prevention: focus on old and New drugs. Pharmacy. 2018;6(1):6. doi: 10.3390/pharmacy6010010
  • Williams B, Mancia G, Spiering W, et al. ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi: 10.1093/eurheartj/ehy339
  • Liberopoulos EN, Florentin M, Mikhailidis DP, et al. Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opin Drug Saf. 2008;7(6):717–725. doi: 10.1517/14740330802396984
  • Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15. doi: 10.1136/bmj.38875.675486.55
  • Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med care. 2005;43(6):521–530. doi: 10.1097/01.mlr.0000163641.86870.af
  • Souza AC, Borges JW, Moreira TM. Quality of life and treatment adherence in hypertensive patients: systematic review with meta-analysis. Rev Saúde Pública. 2016;50:71. doi: 10.1590/s1518-8787.2016050006415
  • Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens Greenwich Conn. 2008;10(5):348–354. doi: 10.1111/j.1751-7176.2008.07572.x
  • Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–1090. discussion 1073. doi: 10.1016/S0149-2918(99)80026-5
  • Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:217047. doi: 10.1155/2015/217047
  • Hamdidouche I, Jullien V, Boutouyrie P, et al. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients. J Hypertens. 2017;35(9):1891–1898. doi: 10.1097/HJH.0000000000001402
  • Osula D, Wu B, Schesing K, et al. Comparison of pharmacy refill data with chemical adherence testing in assessing medication nonadherence in a safety net hospital setting. J Am Heart Assoc. 2022;11(19):e027099. doi: 10.1161/JAHA.122.027099
  • Gellad WF, Thorpe CT, Steiner JF, et al. The myths of medication adherence. Pharmacoepidemiol Drug Saf. 2017 [2017 Oct 11];26(12):1437–1441. doi: 10.1002/pds.4334
  • Will JC, Zhang Z, Ritchey MD, et al. Medication adherence and incident preventable hospitalizations for hypertension. Am J Prev Med. 2016;50(4):489–499. doi: 10.1016/j.amepre.2015.08.021
  • Lucas JE, Bazemore TC, Alo C, et al. An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States military health system. PLoS One. 2017;12(11):e0187809. doi: 10.1371/journal.pone.0187809
  • Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940–2948. doi: 10.1093/eurheartj/eht295
  • De Vera MA, Bhole V, Burns LC, et al. Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review. Br J Clin Pharmacol. 2014 [2014 Nov 5];78(4):684–698. doi: 10.1111/bcp.12339
  • Feng Y, Zhao Y, Yang X, et al. Adherence to antihypertensive medication and cardiovascular disease events in hypertensive patients: a dose–response meta-analysis of 2 769 700 participants in cohort study. QJM: An International Journal Of Medicine. 2021;115(5):279–286. doi: 10.1093/qjmed/hcaa349
  • Sorato MM, Davari M, Kebriaeezadeh A, et al. Reasons for poor blood pressure control in Eastern Sub-Saharan Africa: looking into 4P’s (primary care, professional, patient, and public health policy) for improving blood pressure control: a scoping review. BMC Cardiovasc Disord. 2021;21(1):123. doi: 10.1186/s12872-021-01934-6
  • Tam HL, Wong EML, Cheung K, et al. Effectiveness of text messaging interventions on blood pressure control among patients with hypertension: systematic review of randomized controlled trials. JMIR mHealth uHealth. 2021;9(9):e24527. doi: 10.2196/24527
  • Yao M, Zhou XY, Xu ZJ, et al. The impact of training healthcare professionals’ communication skills on the clinical care of diabetes and hypertension: a systematic review and meta-analysis. BMC Fam Pract. 2021;22(1):152. doi: 10.1186/s12875-021-01504-x
  • Aguiar J, Ribeiro M, Pedro AR, et al. Awareness about barriers to medication adherence in cardiovascular patients and strategies used in clinical practice by Portuguese clinicians: a nationwide study. Int J Clin Pharm. 2021;43(3):629–636. doi: 10.1007/s11096-020-01174-2
  • Van Truong P, Wulan Apriliyasari R, Lin M, et al. Effects of self‐management programs on blood pressure, self‐efficacy, medication adherence and body mass index in older adults with hypertension: Meta‐analysis of randomized controlled trials. Int J Nurs Pract. 2021;27(2):e12920. doi: 10.1111/ijn.12920
  • Tan FCJH, Oka P, Dambha-Miller H, et al. The association between self-efficacy and self-care in essential hypertension: a systematic review. BMC Fam Pract. 2021;22(1):44. doi: 10.1186/s12875-021-01391-2
  • Xu H, Long H. The effect of smartphone app–based interventions for patients with hypertension: systematic review and meta-analysis. JMIR mHealth uHealth. 2020;8(10):e21759. doi: 10.2196/21759
  • Li R, Liang N, Bu F, et al. The effectiveness of self-management of hypertension in adults using mobile health: systematic review and meta-analysis. JMIR mHealth uHealth. 2020;8(3):e17776. doi: 10.2196/17776
  • Hong J, Tiu YC, Leung PYB, et al. Interventions that improve adherence to antihypertensive medications in coronary heart disease patients: a systematic review. Postgrad Med J. 2022;98(1157):219–227. doi: 10.1136/postgradmedj-2020-139116
  • Tan JP, Cheng KKF, Siah RCJ. A systematic review and meta-analysis on the effectiveness of education on medication adherence for patients with hypertension, hyperlipidaemia and diabetes. J Adv Nurs. 2019;75(11):2478–2494. doi: 10.1111/jan.14025
  • Shahaj O, Denneny D, Schwappach A, et al. Supporting self-management for people with hypertension: a meta-review of quantitative and qualitative systematic reviews. J Hypertens. 2019;37(2):264–279. doi: 10.1097/HJH.0000000000001867
  • Cimmaruta D, Lombardi N, Borghi C, et al. Polypill, hypertension and medication adherence: the solution strategy? Int J Cardiol. 2018;252:181–186. doi: 10.1016/j.ijcard.2017.11.075
  • Bramlage P, Ketelhut R, Fronk EM, et al. Clinical impact of patient adherence to a fixed-dose combination of olmesartan, amlodipine and hydrochlorothiazide. Clin Drug Investig. 2014;34(6):403–411. doi: 10.1007/s40261-014-0188-z
  • Bhagavathula AS, Shah SM, Aburawi EH. Medication adherence and treatment-resistant hypertension in newly treated hypertensive patients in the United Arab Emirates. J Clin Med. 2021;10(21):5036. doi: 10.3390/jcm10215036
  • Shani M, Lustman A, Vinker S. Adherence to oral antihypertensive medications, are all medications equal? J Clin Hypertens. 2019;21(2):243–248. doi: 10.1111/jch.13475
  • De Jager RL, van Maarseveen EM, Bots ML, et al. Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial. Br J Clin Pharmacol. 2018;84(1):18–24. doi: 10.1111/bcp.13402
  • De Jager RL, De Beus E, Beeftink MMA, et al. Impact of medication adherence on the effect of renal denervation: the SYMPATHY trial. Hypertension. 2017;69(4):678–684. doi: 10.1161/HYPERTENSIONAHA.116.08818
  • Gupta P, Patel P, Štrauch B, et al. Biochemical screening for nonadherence is associated with blood pressure reduction and improvement in adherence. Hypertension. 2017;70(5):1042–1048. doi: 10.1161/HYPERTENSIONAHA.117.09631
  • Kebede B, Chelkeba L, Dessie B, Rate of blood pressure control and its determinants among adult hypertensive patients at Jimma University Medical Center, Ethiopia: prospective cohort study. SAGE Open Med. 2021; 9: doi: 10.1177/20503121211006000
  • Wu PH, Yang CY, Yao ZL, et al. Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan. Am J Hypertens. 2009;23(2):155–160. doi: 10.1038/ajh.2009.210
  • Overgaauw N, Alsma J, Brink A, et al. Drug nonadherence is a common but often overlooked cause of hypertensive urgency and emergency at the emergency department. J Hypertens. 2019;37(5):1048–1057. doi: 10.1097/HJH.0000000000002005
  • Kim HJ, Kim E, Min KB, et al. Blood pressure and lipid target adherence in Korean patients receiving angiotensin II receptor blockers/statin regimens. Curr Med Res Opin. 2017;33(2):385–390. doi: 10.1080/03007995.2016.1257982
  • Wu JR, Cummings DM, Li Q, et al. The effect of a practice-based multicomponent intervention that includes health coaching on medication adherence and blood pressure control in rural primary care. J Clin Hypertens. 2018;20(4):757–764. doi: 10.1111/jch.13265
  • Ewen S, Meyer MR, Cremers B, et al. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis. Clin Res Cardiol. 2015;104(12):1097–1105. doi: 10.1007/s00392-015-0905-5
  • Yang Q, Chang A, Ritchey MD, et al. Antihypertensive medication adherence and risk of cardiovascular disease among older adults: a population-based cohort study. J Am Heart Assoc. 2017;6(6). doi: 10.1161/JAHA.117.006056
  • Dragomir A, Côté R, Roy L, et al. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs. Med Care. 2010;48(5):418–425. doi: 10.1097/MLR.0b013e3181d567bd
  • Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598–1605. doi: 10.1161/CIRCULATIONAHA.108.830299
  • Degli Esposti L, Saragoni S, Benemei S, et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res. 2011;3:47–54. doi: 10.2147/CEOR.S15619
  • Kim J, Bushnell CD, Lee HS, et al. Effect of adherence to antihypertensive medication on the long-term outcome after hemorrhagic stroke in Korea. Hypertension. 2018;72(2):391–398. doi: 10.1161/HYPERTENSIONAHA.118.11139
  • Ho CT, Tung YC, Chou SH, et al. Clinical outcomes in hypertensive patients treated with a single-pill fixed-dose combination of renin-angiotensin system inhibitor and thiazide diuretic. J Clin Hypertens. 2018;20(12):1731–1738. doi: 10.1111/jch.13413
  • Bailey JE, Wan JY, Tang J, et al. Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death. J Gen Intern Med. 2010;25(6):495–503. doi: 10.1007/s11606-009-1240-1
  • Tsoi KKF, Wong MCS, Tam WWS, et al. Cardiovascular mortality in hypertensive patients newly prescribed perindopril vs. lisinopril: a 5-year cohort study of 15,622 Chinese subjects. Int J Cardiol. 2014;176(3):703–709. doi: 10.1016/j.ijcard.2014.07.114
  • Lee H, Park JH, Floyd JS, et al. Combined effect of income and medication adherence on mortality in newly treated hypertension: nationwide study of 16 million person-years. J Am Heart Assoc. 2019;8(16). doi: 10.1161/JAHA.119.013148
  • Wong MCS, Tam WWS, Wang HHX, et al. Predictors of the incidence of all-cause mortality and deaths due to diabetes and renal diseases among patients newly prescribed antihypertensive agents: a cohort study. Int J Cardiol. 2013;168(5):4705–4710. doi: 10.1016/j.ijcard.2013.07.174
  • Kim S, Shin DW, Yun JM, et al. Medication adherence and the risk of cardiovascular mortality and hospitalization among patients with newly prescribed antihypertensive medications. Hypertension. 2016 [2016 Feb 13];67:506–512.
  • Campbell PJ, Axon DR, Taylor AM, et al. Hypertension, cholesterol and diabetes medication adherence, health care utilization and expenditure in a medicare supplemental sample. Medicine (Baltimore). 2021;100(35):e27143. doi: 10.1097/MD.0000000000027143
  • Lynch WD, Markosyan K, Melkonian AK, et al. Effect of antihypertensive medication adherence among employees with hypertension. Am J Manag Care. 2009;15(12):871–880.
  • Pittman DG, Tao Z, Chen W, et al. Antihypertensive medication adherence and subsequent healthcare utilization and costs. Am J Manag Care. 2010;16:568–576.
  • Yang Z, Howard DH, Will J, et al. Association of antihypertensive medication adherence with healthcare use and Medicaid expenditures for acute cardiovascular events. Med Care. 2016;54(5):504–511. doi: 10.1097/MLR.0000000000000515
  • Roebuck MC, Liberman JN, Gemmill-Toyama M, et al. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff. 2011;30(1):91–99. doi: 10.1377/hlthaff.2009.1087
  • Kymes SM, Pierce RL, Girdish C, et al. Association among change in medical costs, level of comorbidity, and change in adherence behavior. Am J Manag Care. 2016;22(8):e295–301.
  • Qiao Y, Steve Tsang CC, Hohmeier KC, et al. Association between medication adherence and healthcare costs among patients receiving the low-income subsidy. Value Health. 2020;23(9):1210–1217. doi: 10.1016/j.jval.2020.06.005
  • Campbell PJ, Axon DR, Taylor AM, et al. Associations of renin-angiotensin system antagonist medication adherence and economic outcomes among commercially insured us adults: a retrospective cohort study. J Am Heart Assoc. 2020;9(17). doi: 10.1161/JAHA.119.016094
  • Kazerooni R, Watanabe JH, Bounthavong M. Association between statin adherence and cholesterol level reduction from baseline in a veteran population. Pharmacotherapy. 2013;33(10):1044–1052. doi: 10.1002/phar.1305
  • Shalev V, Goldshtein I, Halpern Y, et al. Association between persistence with statin therapy and reduction in low-density lipoprotein cholesterol level: analysis of real-life data from community settings. Pharmacotherapy. 2014;34(1):1–8. doi: 10.1002/phar.1326
  • Yeo SH, Toh MPHS, Lee SH, et al. Impact of medication nonadherence on stroke recurrence and mortality in patients after first-ever ischemic stroke: insights from registry data in Singapore. Pharmacoepidemiol Drug Saf. 2020;29:538–549. doi: 10.1002/pds.4981
  • Hero C, Karlsson SA, Franzén S, et al. Adherence to lipid-lowering therapy and risk for cardiovascular disease and death in type 1 diabetes mellitus: a population-based study from the Swedish national diabetes register. BMJ Open Diabetes Res Care. 2020;8(1):e000719. doi: 10.1136/bmjdrc-2019-000719
  • Perreault S, Ellia L, Dragomir A, et al. Effect of statin adherence on cerebrovascular disease in primary prevention. Am J Med. 2009;122(7):647–655. doi: 10.1016/j.amjmed.2009.01.032
  • Pittman DG, Chen W, Bowlin SJ, et al. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol. 2011;107(11):1662–1666. doi: 10.1016/j.amjcard.2011.01.052
  • Parati G, Kjeldsen S, Coca A, et al. Adherence to single-pill versus free-equivalent combination therapy in Hypertens Dallas tex 1979: a systematic review and meta-analysis. Hypertension. 2021;77(2):692–705. doi: 10.1161/HYPERTENSIONAHA.120.15781
  • Gallo G, Sarzani R, Cicero AFG, et al. An Expert opinion on the role of the Rosuvastatin/Amlodipine single pill fixed dose combination in cardiovascular prevention. High Blood Press Cardiovasc Prev. 2023;30(2):83–91. doi: 10.1007/s40292-023-00570-9